Cargando…
Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs
BACKGROUND: This study aimed to investigate existing trialling activity relating to three antipsychotic drugs from the WHO List of Essential Medicines (chlorpromazine, fluphenazine decanoate, haloperidol), link existing trials to existing Cochrane reviews, identify gaps in reviewing activity on acce...
Autores principales: | Purgato, Marianna, Barbui, Corrado, Adams, Clive E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204288/ https://www.ncbi.nlm.nih.gov/pubmed/21943196 http://dx.doi.org/10.1186/1752-4458-5-25 |
Ejemplares similares
-
Forty-five years of schizophrenia trials in Italy: a survey
por: Purgato, Marianna, et al.
Publicado: (2012) -
Schizophrenia trials conducted in African countries: a drop of evidence in the ocean of morbidity?
por: Purgato, Marianna, et al.
Publicado: (2012) -
Prioritising Cochrane reviews to be updated with health equity focus
por: Tomlinson, Eve, et al.
Publicado: (2023) -
S204. REDUCTION OF ANTIPSYCHOTIC DOSES AND POLYPHARMACY: TWO COCHRANE REVIEWS
por: Leucht, Stefan, et al.
Publicado: (2020) -
Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies
por: Turrini, Giulia, et al.
Publicado: (2017)